Intellia Therapeutics's total assets for Q4 2024 were $1.19B, an increase of 1.51% from the previous quarter. NTLA total liabilities were $319.06M for the fiscal quarter, a 51.40% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.